Jakarta, IDN Times – A total of 500 thousand Johnson & Johnson vaccines have been received by the Indonesian government on Saturday (11/9/2021). The procurement of this vaccine is the result of cooperation between the Indonesian government and the Netherlands through a bilateral scheme.
It is known that Johnson & Johnson Vaccines have obtained an emergency use permit or EUA (Emergency Use Authorization) from the Food and Drug Supervisory Agency (BPOM) on 7 September 2021.
This vaccine will be used for the general public aged 18 years and over with a single dose of 0.5 milliterm. So what are the side effects of this vaccine?
1. Johnson & Johnson Vaccine AEFIs are generally painful and feverish
Head of the POM RI, Penny K. Lukito, said the results of the study showed that from a safety perspective, in general, the administration of the Johnson & Johnson vaccine was well tolerated.
Both local and systemic reactions to the Johnson & Johnson vaccine are graded 1 and 2 in severity.
Adverse events after immunization (AEFI/side effects) that commonly occur locally include pain, redness, and swelling, as well as systemic AEFIs that commonly occur are headache, fatigue (fatique), muscle ache (myalgia), drowsiness, nausea (nausea), vomiting, fever (pyrexia), and diarrhea.
Continue reading the article below
2. One-shot Johnson & Johnson vaccine
Meanwhile, the indications for the use of the Johnson & Johnson vaccine are in people aged 18 years and over, by giving one injection or a single dose of 0.5 milliliters intramuscularly.
Johnson & Johnson vaccine requires storage conditions at a special temperature, which is 2 to 8 degrees, besides that it can also be stored at a temperature of minus 20 degrees Celsius.
3. BPOM ensures compliance with vaccine safety, efficacy and quality standards
BPOM always collaborates with experts in ensuring compliance with vaccine safety, efficacy and quality standards.
“We involve experts in the fields of pharmacology, immunology, clinicians, pharmacists, epidemiology, virology, and biomedicine who are members of the National Committee for the Special Assessment of the Corona Virus Disease 2019 (COVID-19) Vaccine. Indonesia Technical Advisory Group on Immunization (ITAGI), as well as related clinician associations,” explained Penny as quoted on the official BPOM website, Wednesday (13/9/2021).